Author Correction: Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid in vitro

被引:0
|
作者
Han Qiao
Ting-yu Wang
Wei Yan
An Qin
Qi-ming Fan
Xiu-guo Han
Yu-gang Wang
Ting-ting Tang
机构
[1] Shanghai Jiao Tong University School of Medicine,Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery
[2] Shanghai Jiao Tong University School of Medicine,Department of Pharmacy, Shanghai Ninth People’s Hospital
[3] Wendeng Zhenggu Hospital of Shandong Province,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The authors regretted to find the mis-representative images in Fig. 3a, c and Fig. 4a, c when re-read our previously published article Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro (DOI: 10.1038/aps.2015.42) in the journal of Acta Pharmacologica Sinica. This mistake occurred due to the careless compilation when the authors tried to show the synergistic effect against tumor apoptosis during figure presentation process. The right Fig. 3a, c and Fig. 4a, c were provided below. Despite that this correction does not affect the results and conclusions of the aforementioned paper, all the authors still consent on the correction of this negligence. We apologize to the Editor and the readership of the journal for any inconvenience caused. Your thoughtful understanding is highly appreciated.
引用
收藏
页码:1127 / 1128
页数:1
相关论文
共 50 条
  • [1] Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro
    Han Qiao
    Ting-yu Wang
    Wei Yan
    An Qin
    Qi-ming Fan
    Xiu-guo Han
    Yu-gang Wang
    Ting-ting Tang
    [J]. Acta Pharmacologica Sinica, 2015, 36 : 1085 - 1098
  • [2] Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid in vitro
    Qiao, Han
    Wang, Ting-yu
    Yan, Wei
    Qin, An
    Fan, Qi-ming
    Han, Xiu-guo
    Wang, Yu-gang
    Tang, Ting-ting
    [J]. ACTA PHARMACOLOGICA SINICA, 2015, 36 (09) : 1085 - 1098
  • [3] Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid in vitro (vol 36, pg 1085, 2015)
    Qiao, Han
    Wang, Ting-yu
    Yan, Wei
    Qin, An
    Fan, Qi-ming
    Han, Xiu-guo
    Wang, Yu-gang
    Tang, Ting-ting
    [J]. ACTA PHARMACOLOGICA SINICA, 2019, 40 (08) : 1127 - 1128
  • [4] In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells
    Ural, A. Ugur
    Avcu, Ferit
    Candir, Muhammed
    Guden, Metin
    Ozcan, M. Ali
    [J]. BREAST CANCER RESEARCH, 2006, 8 (04)
  • [5] Zoledronic acid (ZOL) in combination with doxorubicin (DOX) has synergistic effects on apoptosis of breast cancer cells (BCCs) in vitro
    Neville-Webbe, HL
    Evans, CA
    Coleman, RE
    Holen, I
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1598 - 1598
  • [6] Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acid
    Ullén, A
    Lennartsson, L
    Harmenberg, U
    Hjelm-Eriksson, M
    Kalkner, KM
    Lennernäs, B
    Nilsson, S
    [J]. ACTA ONCOLOGICA, 2005, 44 (06) : 644 - 650
  • [7] Growth inhibition in human breast cancer cells with the combination of a PKC inhibitor and zoledronic acid.
    Witters, LM
    Green, J
    Seaman, J
    Lipton, A
    Milton, S
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S166 - S166
  • [8] In vitro synergistic effects of zoledronic acid and calcium on viability of human epithelial cells
    Arai, N.
    Inoue, S.
    Tomihara, K.
    Tsuno, H.
    Noguchi, M.
    [J]. ORAL DISEASES, 2013, 19 (02) : 200 - 205
  • [9] The effects of zoledronic acid and doxorubicin in combination on breast cancer cell invasion in vitro
    Woodward, JKL
    Neville-Webbe, H
    Coleman, RE
    Holen, I
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (07) : 1299 - 1299
  • [10] Mechanisms of the synergistic interaction between the bisphosphonate zoledronic acid and the chemotherapy agent paclitaxel in breast cancer cells in vitro
    Neville-Webbe, HL
    Evans, CA
    Colemana, RE
    Holen, I
    [J]. TUMOR BIOLOGY, 2006, 27 (02) : 92 - 103